Scoop has an Ethical Paywall
Cancer detection commercialisation can't be 'overnight'
Cancer detection commercialisation could never be an 'overnight' happening
By Peter Kerr for sticK
(sticK - 30 Nov. 2010 ) Pacific Edge Ltd., is inching its way to commercialisation of its bladder cancer detection tests - showing that it can be done, but never 'overnight'.
Above all it also demonstrates just how much effort it takes to turn an idea, detecting the presence of cancer cells in urine, and turning that into a sellable product - an assay test that is easily and accurately able to be used by urologists and physicians as a diagnostic and prognosis tool.
Along the way the Dunedin-based company has had to prove its methodology in different locations; so far in Australasia, America and Europe, and is now working on the best way to commercially roll out the tests.
For sticK – science, technology, innovation &
commercialisation KNOWLEDGE - is a new Wellington based
news service concentrating on following the money from ideas
to income. Contact editor Peter Kerr at peter.kerr055 @
gmail.com
Peter Kerr
Message maker
Writer, communicator, simplifier, storyteller.
Versed in the art and science of translating something complicated into an understandable message.
Air NZ: Ka Rere - Air New Zealand Championing Māori And Pasifika-Owned Businesses
Wellington Airport: Half-Year Unaudited Results To 30 September 2024
Greenpeace: Seabed Mining Sinks Offshore Wind Industry
PSA: Lives Of Workers At Risk From Latest WorkSafe Restructure Plan
Foodstuffs NZ: Foodstuffs Co-Ops To Examine ComCom's Full Decision Before Deciding On Merger Appeal
Plant and Food Research: World First Discovery Shows New Molecule In New Zealand Blackcurrants Inhibits An Enzyme That Degrades Dopamine
